Transcept Pharmaceuticals (TSPT) jumps 28% higher after the firm announces the FDA has assigned...

|By:, SA News Editor

Transcept Pharmaceuticals (TSPT) jumps 28% higher after the firm announces the FDA has assigned Nov. 27 as an action date for its review of Intermezzo, following up an earlier positive review of the prescription sleeping aid by the regulator.